Related Experiment Videos
A randomized trial comparing anti-interleukin-2 receptor antibody and placebo for immunosuppressive therapy after OLT
J M Langrehr1, M Glanemann, A Schneller
1Department of Surgery, Virchow-Klinikum, Humboldt University Berlin, Germany.
Transplantation Proceedings
|June 24, 1998
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Protein kinase C inhibitor sotrastaurin in de novo liver transplant recipients: a randomized phase II trial.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2015
Estimating the contribution of everolimus to immunosuppressive efficacy when combined with tacrolimus in liver transplantation: a model-based approach.
Clinical pharmacology and therapeutics·2015
Efficacy of sotrastaurin plus tacrolimus after de novo kidney transplantation: randomized, phase II trial results.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2013
Sotrastaurin in calcineurin inhibitor-free regimen using everolimus in de novo kidney transplant recipients.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2013
Gastrointestinal Bleeding From Enteric Anastomosis in Simultaneous Pancreas/Kidney Transplantation: A Novel Hybrid Approach.
Transplantation proceedings·2026
Machine Perfusion Parameters and 1-Year Outcomes in High KDPI Kidney Transplantation: A Single-Center Cohort Study.
Transplantation proceedings·2026
Microbial and Proteomic Signature of Acute Cellular Rejection in Lung Transplants.
Transplantation proceedings·2026
Treatment patterns, access, and multidimensional burden of myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) in China: A nationwide cross-sectional study.
Therapeutic advances in neurological disorders·2026
Efficacy and safety of interleukin-6 receptor inhibitors in myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): A systematic review and meta-analysis.
Therapeutic advances in neurological disorders·2026